File Download
  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Variation by lineage in serum antibody responses to influenza B virus infections

TitleVariation by lineage in serum antibody responses to influenza B virus infections
Authors
Issue Date2020
PublisherPublic Library of Science. The Journal's web site is located at http://www.plosone.org/home.action
Citation
PLoS One, 2020, v. 15 n. 11, p. article no. e0241693 How to Cite?
AbstractTwo lineages of influenza B virus currently co-circulate and have distinct antigenicity, termed Victoria and Yamagata after the B/Victoria/2/87 and B/Yamagata/16/88 strains, respectively. We analyzed antibody titer dynamics following PCR-confirmed influenza B virus infection in a longitudinal community-based cohort study conducted in Hong Kong from 2009–2014 to assess patterns in changes in antibody titers to B/Victoria and B/Yamagata viruses following infections with each lineage. Among 62 PCR-confirmed cases, almost half had undetectable hemagglutination inhibition (HAI) antibody titers to the lineage of infection both pre-infection and post-infection. Among those infected with influenza B/Victoria who showed an HAI titer response after infection, we found strong rises to the lineage of infection, positive but smaller cross-lineage HAI titer boosts, a small dependence of HAI titer boosts on pre-infection titers, and a shorter half-life of HAI titers in adults. Our study is limited by the low HAI sensitivity for non-ether-treated IBV antigen and the incapacity of performing other assays with higher sensitivity, as well as the mismatch between the B/Yamagata lineage circulating strain and the assay strain in one of the study seasons.
Persistent Identifierhttp://hdl.handle.net/10722/305233
ISSN
2023 Impact Factor: 2.9
2023 SCImago Journal Rankings: 0.839
PubMed Central ID
ISI Accession Number ID

 

DC FieldValueLanguage
dc.contributor.authorLau, YC-
dc.contributor.authorPerera, RAPM-
dc.contributor.authorFang, VJ-
dc.contributor.authorLuk, LH-
dc.contributor.authorChu, DKW-
dc.contributor.authorWu, P-
dc.contributor.authorBarr, IG-
dc.contributor.authorPeiris, JSM-
dc.contributor.authorCowling, BJ-
dc.date.accessioned2021-10-20T10:06:31Z-
dc.date.available2021-10-20T10:06:31Z-
dc.date.issued2020-
dc.identifier.citationPLoS One, 2020, v. 15 n. 11, p. article no. e0241693-
dc.identifier.issn1932-6203-
dc.identifier.urihttp://hdl.handle.net/10722/305233-
dc.description.abstractTwo lineages of influenza B virus currently co-circulate and have distinct antigenicity, termed Victoria and Yamagata after the B/Victoria/2/87 and B/Yamagata/16/88 strains, respectively. We analyzed antibody titer dynamics following PCR-confirmed influenza B virus infection in a longitudinal community-based cohort study conducted in Hong Kong from 2009–2014 to assess patterns in changes in antibody titers to B/Victoria and B/Yamagata viruses following infections with each lineage. Among 62 PCR-confirmed cases, almost half had undetectable hemagglutination inhibition (HAI) antibody titers to the lineage of infection both pre-infection and post-infection. Among those infected with influenza B/Victoria who showed an HAI titer response after infection, we found strong rises to the lineage of infection, positive but smaller cross-lineage HAI titer boosts, a small dependence of HAI titer boosts on pre-infection titers, and a shorter half-life of HAI titers in adults. Our study is limited by the low HAI sensitivity for non-ether-treated IBV antigen and the incapacity of performing other assays with higher sensitivity, as well as the mismatch between the B/Yamagata lineage circulating strain and the assay strain in one of the study seasons.-
dc.languageeng-
dc.publisherPublic Library of Science. The Journal's web site is located at http://www.plosone.org/home.action-
dc.relation.ispartofPLoS One-
dc.rightsThis work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.-
dc.titleVariation by lineage in serum antibody responses to influenza B virus infections-
dc.typeArticle-
dc.identifier.emailLau, YC: chunglau@hku.hk-
dc.identifier.emailLuk, LH: lhluk@hku.hk-
dc.identifier.emailWu, P: pengwu@hku.hk-
dc.identifier.emailPeiris, JSM: malik@hkucc.hku.hk-
dc.identifier.emailCowling, BJ: bcowling@hku.hk-
dc.identifier.authorityPerera, RAPM=rp02500-
dc.identifier.authorityChu, DKW=rp02512-
dc.identifier.authorityWu, P=rp02025-
dc.identifier.authorityPeiris, JSM=rp00410-
dc.identifier.authorityCowling, BJ=rp01326-
dc.description.naturepublished_or_final_version-
dc.identifier.doi10.1371/journal.pone.0241693-
dc.identifier.pmid33166348-
dc.identifier.pmcidPMC7652285-
dc.identifier.scopuseid_2-s2.0-85095961926-
dc.identifier.hkuros327080-
dc.identifier.volume15-
dc.identifier.issue11-
dc.identifier.spagearticle no. e0241693-
dc.identifier.epagearticle no. e0241693-
dc.identifier.isiWOS:000592382600021-
dc.publisher.placeUnited States-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats